
Loading, please wait...

Loading, please wait...

The FDA recently highlighted a significant Boston Scientific heart recall affecting various cardiac devices. This regulatory action follows reports of several deaths and thousands of serious injuries. Therefore, clinicians must stay informed about the required corrections. However, the FDA does not recommend removing the devices from patients. Instead, doctors should update the software during scheduled clinic visits. Consequently, this measure aims to mitigate risks without invasive surgery.
The affected hardware includes the Accolade, Essentio, and Proponent models, among others. Specifically, these pacemakers and cardiac resynchronization therapy devices require the Brady SMR6 software patch. Boston Scientific developed this patch to fix issues stemming from a previous software version. Furthermore, the agency is monitoring additional updates regarding a potential battery drain issue. Thus, timely intervention is essential for patient safety.
Doctors must prioritize patients who are at higher risk. For instance, individuals with low battery life or those who rely entirely on the device need immediate follow-up. In addition, routine monitoring remains standard for other patients. Because the recall is Class I, the risks of inaction are severe. Consequently, medical teams should coordinate these updates promptly. This proactive approach ensures that the devices function correctly and prevent future complications.
Q1: Do these devices need to be surgically removed?
No, the FDA does not recommend device explant. Instead, a software update during an in-person clinic visit is sufficient to address the issue.
Q2: Which models are affected by this recall?
The recall involves the Accolade, Essentio, Proponent, Altrua 2, Valitude, and Visionist pacemakers and CRT devices.
Q3: What is the risk if the software is not updated?
Failure to update the software can lead to serious injury or death, as the correction fixes critical logic errors.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Boston Scientific issues a Class I recall for pacemakers like Accolade and Proponent. Software updates are required to address serious safety issues and dea...
2 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today